Spyre Therapeutics News and Activities

Presence

Spyre Therapeutics develops biotechnology medicines for inflammatory bowel disease. Its main products and services include antibody therapies, drug research, and clinical development for patients, healthcare providers, and biopharma partners.

Spyre Therapeutics products and services overview:

  • Antibody therapies
  • Drug discovery
  • Clinical development
  • Biologic medicines

Revenue: ~$0 million

Employees: 60

Headquarters: Waltham, United States (USA)


Spyre Therapeutics is one of the...

Spyre Therapeutics is a company listed under the stock ticker AGLE (US).

Acquisition, funding and merger involving Spyre Therapeutics.

Executives

View the org chart displaying its 28 main executives

Most searched biographies at Spyre Therapeutics
Popular executive movements at Spyre Therapeutics
  • Peter Harwin, Director, has left the company  (posted on June 1 2026).

Create your alert
to follow the executive moves at Spyre Therapeutics.

Biotechnology

Spyre Therapeutics has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology
Popular contacts in Biotechnology

Learn more about the Biotechnology industry

News

Press releases by Spyre Therapeutics
Social media about Spyre Therapeutics

Get in Touch

Call Spyre Therapeutics at +1 512...

View the org chart

Register to receive your alert

Report an error

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.

Individual Access Data & API
Executives
Companies
The Official Board